Investment Summary

The Carlyle Group Invests In Ambiopharm

On September 10, 2018, private equity firm The Carlyle Group invested in life science company Ambiopharm

Investment Highlights
  • This is The Carlyle Group’s 11th transaction in the Life Science sector.
  • This is The Carlyle Group’s 302nd transaction in the United States.
  • This is The Carlyle Group’s 3rd transaction in South Carolina.

Investment Summary
Date 2018-09-10
Target Ambiopharm
Sector Life Science
Investor(s) The Carlyle Group
Deal Type Stake Purchase

Target

Ambiopharm

North Augusta, South Carolina, United States
Ambiopharm is a peptide biologics company that provides API CDMO services for drugs approved by US food and drug administration, European Medicines Agency and China National Medical Products Administration and has a robust pipeline of pre-clinical and clinical programs. The firm also partners with major global pharmaceutical firms to develop generic peptides. Ambiopharm was founded in 2007 and is based in North Augusta, South Carolina.

Search 200,626 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

The Carlyle Group

Washington, District of Columbia, United States

Investor Investor Investor Investor Investor

Category Private Equity Firm
Founded 1987
PE ASSETS 435.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION
Carlyle's corporate headquarters on Pennsylvania Ave. in Washington, DC.
Carlyle's corporate headquarters on Pennsylvania Ave. in Washington, DC.

The Carlyle Group is a global investment firm that pursues private equity, credit, and real estate investments worldwide. Carlyle's private equity practice practice pursues buyouts, strategic minority equity investments, equity private placements, consolidations and buildups, and growth capital financings. With offices in 19 countries, Carlyle can easily target opportunities throughout North America, Europe, Asia, Australia, the Middle East/North Africa and Latin America. Broad sectors of interest include aerospace, defense, automotive and transportation, consumer, retail, energy and power, financial services, healthcare, industrial, infrastructure, technology services, business services, telecommunications and media. The Carlyle Group was formed in 1987 and is based in Washington DC.

DEAL STATS #
Overall 624 of 744
Sector (Life Science) 11 of 19
Type (Stake Purchase) 57 of 73
State (South Carolina) 3 of 4
Country (United States) 302 of 349
Year (2018) 15 of 25
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2018-09-05 Valcour Wind Energy

Albany, New York, United States

Valcour Wind Energy operates a wind generation portfolio in New York along with a dedicated operations platform. The portfolio comprises six distinct wind farms located in Northern and Western New York.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-09-12 Sedgwick

Memphis, Tennessee, United States

Sedgwick is a global provider of technology-enabled risk, benefits and integrated business solutions. The Company provides technology-enabled claims management solutions for workers’ compensation, disability, liability, and property claims. Sedgwick was founded in 1969 and is based in Memphis, Tennessee.

Buy $6.7B
Mergr

Product

Company

Legal